We are live on ! Find out more
AKTX

Akari Therapeutics
AKTX

19 hedge funds and large institutions have $6.34M invested in Akari Therapeutics in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

89% more capital invested

Capital invested by funds: $3.35M → $6.34M (+$2.99M)

58% more funds holding

Funds holding: 12 → 19 (+7)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
19
Holders Change
+7
Holders Change %
+58.33%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UAS
United Asset Strategies
New York
+$571K
2
OFW
Omnia Family Wealth
Florida
+$395K
3
Millennium Management
Millennium Management
New York
+$51.8K
4
Citadel Advisors
Citadel Advisors
Florida
+$36.6K
5
Squarepoint
Squarepoint
New York
+$36.6K

Top Sellers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
-$24K
2
UBS Group
UBS Group
Switzerland
-$9.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
HP
1
Hikari Power
Japan
$3.27M – – –
NMC
2
NEA Management Company
Maryland
$986K – – –
OFW
3
Omnia Family Wealth
Florida
$854K +$395K +259 +113%
UAS
4
United Asset Strategies
New York
$654K +$571K +375 New
Renaissance Technologies
5
Renaissance Technologies
New York
$291K +$7.62K +5 +3%
Millennium Management
6
Millennium Management
New York
$59K +$51.8K +34 New
Citadel Advisors
7
Citadel Advisors
Florida
$41K +$36.6K +24 New
Squarepoint
8
Squarepoint
New York
$41K +$36.6K +24 New
VF
9
Virtu Financial
New York
$40K +$35K +23 New
Envestnet Asset Management
10
Envestnet Asset Management
Illinois
$29K +$3.05K +2 +13%
HF
11
HRT Financial
New York
$26K +$22.9K +15 New
PNC Financial Services Group
12
PNC Financial Services Group
Pennsylvania
$26K +$22.9K +15 New
Bank of America
13
Bank of America
North Carolina
$7K – – –
PCG
14
Private Capital Group
Connecticut
$5K – – –
TC
15
Truvestments Capital
Florida
$4K +$4.57K +3 New
Morgan Stanley
16
Morgan Stanley
New York
$2K – – –
Osaic Holdings
17
Osaic Holdings
Arizona
$2K – – –
PFGIA
18
Patriot Financial Group Insurance Agency
Massachusetts
$2K – – –
UBS Group
19
UBS Group
Switzerland
$1K -$9.14K -6 -86%
HighTower Advisors
20
HighTower Advisors
Illinois
– -$24K -20 Closed

AKTX Hedge Fund Activity: Q2 2020 in Review

19 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q2 2020, worth a combined $6.34M — up 89% from $3.35M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AKTX positions and 1 closed out — a net gain of 7 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was United Asset Strategies, opening a new position worth an estimated $571K. The largest seller was HighTower Advisors, exiting entirely with an estimated $24K sold.

  • 19 institutional investors held Akari Therapeutics (AKTX) as of Q2 2020, up from 12 in Q1 2020.
  • Funds reported $6.34M of Akari Therapeutics stock for Q2 2020, up 89% quarter-over-quarter.
  • 8 funds opened new Akari Therapeutics positions in Q2 2020 and 1 closed out, a net change of +7 holders.
  • The largest Akari Therapeutics buyer in Q2 2020 was United Asset Strategies, an estimated $571K added.
  • The largest Akari Therapeutics seller in Q2 2020 was HighTower Advisors, an estimated $24K sold.

Based on aggregated 13F filings for Q2 2020.